KCKalipso Chalkidou

Kalipso Chalkidou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kalipso Chalkidou has a total of 204 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Gender bias in health financing methods: metrics and data

    by Kalipso Chalkidou, Richard Sullivan

    ‘[power’s] success is proportional to its ability to hide its own mechanisms’. The lancet commission: Women, power and cancer investigates, exposes and challenges the prevailing asymmetries of power in relation to cancer in three domains: Decision-making, knowledge and economics. Its findings build on a long history of scholarship on gender inequality moving beyond traditional frameworks captured by sustainable development goal (sdg) 5, by applying feminist values and principles of social and gender justice and equity in relation to the experience of cancer around the globe. The sobering reality is that, based on current data, it will take 134 years to reach full parity—roughly five generations beyond the 2030 sdg target. Inspired by this work, we discuss three types of gender bias not surfaced by the commission, which remain hidden in economic methods, metrics and data widely used in the field of health financing and posit that these ‘hidden power mechanisms’ perpetuate gender bias and patriarchal norms.


  • Enhancing the value of public spending on health technology around the world

    by Ryan Jonathan Sitanggang, Kinanti Khansa Chavarina, Kalipso Chalkidou, Fiona Pearce, Yot Teerawattananon

    The implementation of Universal Health Coverage programmes in numerous countries has given rise to significant financial challenges. The absence of a well-defined process for determining and revising health service coverage has led to implicit and unpredictable rationing decisions among patients, service providers, and payers, thereby impeding the efficient and equitable allocation of resources. To address this, countries use various methods, such as health technology assessment, to prioritise health interventions for Universal Health Coverage programmes. Many countries, particularly in resource-constrained settings, look up to established health technology assessment processes like those operated by the National Institute for Health and Care Excellence (NICE) to improve their own processes. This chapter delves into the global viewpoint of NICE, drawing insights from a survey of health technology assessment organisations to assess its influence and impact on the international health technology assessment landscape. Additionally, the chapter discusses the role of NICE International in supporting the worldwide development of health technology assessment, emphasising the need for collaborative efforts among health technology assessment agencies on a global scale.

  • Open Access

    We need to talk about values: a proposed framework for the articulation of normative reasoning in health technology assessment

    by Victoria Charlton, Michael DiStefano, Polly Mitchell, Liz Morrell, Leah Rand, Gabriele Badano, Rachel Baker, Michael Calnan, Kalipso Chalkidou, Anthony Culyer, et al.

    It is acknowledged that health technology assessment (HTA) is an inherently value-based activity that makes use of normative reasoning alongside empirical evidence. But the language used to conceptualise and articulate HTA's normative aspects is demonstrably unnuanced, imprecise, and inconsistently employed, undermining transparency and preventing proper scrutiny of the rationales on which decisions are based. This paper – developed through a cross-disciplinary collaboration of 24 researchers with expertise in healthcare priority-setting – seeks to address this problem by offering a clear definition of key terms and distinguishing between the types of normative commitment invoked during HTA, thus providing a novel conceptual framework for the articulation of reasoning. Through application to a hypothetical case, it is illustrated how this framework can operate as a practical tool through which HTA practitioners and policymakers can enhance the transparency and coherence of their decision-making, while enabling others to hold them more easily to account. The framework is offered as a starting point for further discussion amongst those with a desire to enhance the legitimacy and fairness of HTA by facilitating practical public reasoning, in which decisions are made on behalf of the public, in public view, through a chain of reasoning that withstands ethical scrutiny.


  • Open Access

    Avoiding health technology assessment: a global survey of reasons for not using health technology assessment in decision making

    by Yot Teerawattananon, Chris Painter, Saudamini Dabak, Trygve Ottersen, Unni Gopinathan, Lumbwe Chola, Kalipso Chalkidou, Anthony J. Culyer

    Introduction: Despite the documented benefits of using health technology assessments (HTA) to inform resource allocation in health care systems, HTA remains underused, especially in low- and middle-income countries. A survey of global health practitioners was conducted to reveal the top reasons (“excuses”) that they had heard from colleagues, policymakers or other stakeholders for not using HTA in their settings. Methods: There were 193 respondents to the survey. Most responses were from individuals in research organisations (37%), ministries of health (27%) and other government agencies (14%). Participants came from Southeast Asia (40%), the Western Pacific (30%), Africa (15%), Europe (7%), the Americas (7%) and the Eastern Mediterranean region (2%). Results: The top five reasons encountered by respondents related to lack of data, lack of technical skills for HTA, the technocratic nature of the work, the lack of explicit decision rules and the perception that HTA puts a “price on life”. Conclusions: This study aimed to understand and address the top reasons for not using HTA. They fall into three categories: (1) misconceptions about HTA; (2) feasibility issues; and (3) values, attitudes and politics. Previous literature has shown that these reasons can be addressed when identified, and even imperfect HTA analyses can provide useful information to a decision-maker.


  • Open Access

    Evaluations of public health interventions produced by health technology assessment agencies: A mapping review and analysis by type and evidence content

    by Pascale Renée Cyr, Vageesh Jain, Kalipso Chalkidou, Trygve Ottersen, Unni Gopinathan


  • Open Access

    Health technology assessment in sub-Saharan Africa: a descriptive analysis and narrative synthesis

    by Samantha Hollingworth, Ama Pokuaa Fenny, Su-Yeon Yu, Francis Ruiz, Kalipso Chalkidou

    Background: Countries in Sub-Saharan Africa (SSA) are moving towards universal health coverage. The process of Health Technology Assessment (HTA) can support decisions relating to benefit package design and service coverage. HTA involves institutional cooperation with agreed methods and procedural standards. We systematically reviewed the literature on policies and capacity building to support HTA institutionalisation in SSA. Methods: We systematically reviewed the literature by searching major databases (PubMed, Embase, etc.) until June 2019 using terms considering three aspects: HTA; health policy, decision making; and SSA. We quantitatively extracted and descriptively analysed content and conducted a narrative synthesis eliciting themes from the selected literature, which varied in study type and apporach. Results: Half of the 49 papers identified were primary research studies and mostly qualitative. Five countries were represented in six of ten studies; South Africa, Ghana, Uganda, Cameroon, and Ethiopia. Half of first authors were from SSA. Most informants were policy makers. Five themes emerged: (1) use of HTA; (2) decision-making in HTA; (3) values and criteria for setting priority areas in HTA; (4) involving stakeholders in HTA; and (5) specific examples of progress in HTA in SSA. The first one was the main theme where there was little use of evidence and research in making policy. The awareness of HTA and economic evaluation was low, with inadequate expertise and a lack of local data and tools. Conclusions: Despite growing interest in HTA in SSA countries, awareness remains low and HTA-related activities are uncoordinated and often disconnected from policy. Further training and skills development are needed, firmly linked to a strategy focusing on strengthening within-country partnerships, particularly among researchers and policy makers. The international community has an important role here by supporting policy- relevant technical assistance, highlighting that sustainable financing demands evidence-based processes for effective resource allocation, and catalysing knowledge-sharing opportunities among countries facing similar challenges.


  • Open Access

    Ending AIDS as a public health threat by 2030: Time to reset targets for 2025

    by Paul R. De Lay, Adèle Benzaken, Quarraisha Abdool Karim, Sani Aliyu, Carolyn Amole, George Ayala, Kalipso Chalkidou, Judy Chang, Michaela Clayton, Aleny Couto, et al.

    Paul De Lay and co-authors introduce a Collection on the design of targets for ending the AIDS epidemic.


  • Open Access

    Evidence-Informed Deliberative Processes for HTA Around the Globe: Exploring the Next Frontiers of HTA and Best Practices Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"

    by Unni Gopinathan, Trygve Ottersen, Pascale-Renée Cyr, Kalipso Chalkidou

    This comment reflects on an article by Oortwijn, Jansen, and Baltussen about the use and features of ‘evidence-informed deliberative processes’ (EDPs) among health technology assessment (HTA) agencies around the world and the need for more guidance. First, we highlight procedural aspects that are relevant across key steps of EDP, focusing on conflict of interest, the different roles of stakeholders throughout a HTA and public justification of decisions. Second, we discuss new knowledge and models needed to maximize the value of deliberative processes at the expanding frontiers of HTA, paying special attention to when HTA is applied in primary care, employed for public health interventions, and is produced through international collaboration.


  • Open Access

    What do we need to know? Data sources to support evidence-based decisions using health technology assessment in Ghana

    by Samantha A. Hollingworth, Laura Downey, Francis J. Ruiz, Emmanuel Odame, Lydia Dsane-Selby, Martha Gyansa-Lutterodt, Justice Nonvignon, Kalipso Chalkidou

    Background: Evidence-based decision-making for prioritising health is assisted by health technology assessment (HTA) to integrate data on effectiveness, costs and equity to support transparent decisions. Ghana is moving towards universal health coverage, facilitated mainly by the National Health Insurance Scheme (NHIS) established in 2003. The Government of Ghana is committed to institutionalising HTA for priority-setting. We aimed to identify and describe the sources of accessible data to support HTA in Ghana.Methods: We identified and described data sources encompassing six main domains using an existing framework. The domains were epidemiology, clinical efficacy, costs, health service use and consumption, quality of life, and equity. We used existing knowledge, views of stakeholders, and searches of the literature and internet.Results: The data sources for each of the six domains vary in extent and quality. Ghana has several large data sources to support HTA (e.g. Demographic Health Surveys) that have rigorous quality assurance processes. Few accessible data sources were available for costs and resource utilisation. The NHIS is a potentially rich source of data on resource use and costs but there are some limits on access. There are some data on equity but data on quality of life are limited.Conclusions: A small number of quality data sources are available in Ghana but there are some gaps with respect to HTA based on greater use of local and contextualised information. Although more data are becoming available for monitoring, challenges remain in terms of their usefulness for HTA, and some information may not be available in disaggregated form to enable specific analyses. We support recent initiatives for the routine collection of comprehensive and reliable data that is easily accessible for HTA users. A commitment to HTA will require concerted efforts to leverage existing data sources, for example, from the NHIS, and develop and maintain new data (e.g. local health utility estimates). It will be critical that an overarching strategic and mandatory approach to the collection and use of health information is developed for Ghana in parallel to, and informed by, the development of HTA approaches to support resource allocation decisions. The key to HTA is to use the best available data while being open about its limitations and the impact on uncertainty.


  • Open Access

    Value-based tiered pricing for universal health coverage: an idea worth revisiting

    by Kalipso Chalkidou, Karl Claxton, Rachel Silverman, Prashant Yadav

    The pricing of medicines and health products ranks among the most hotly debated topics in health policy, generating controversy in richer and poorer markets alike. Creating the right pricing structure for pharmaceuticals and other healthcare products is particularly important for low- and middle-income countries, where pharmaceuticals account for a significant portion of total health expenditure; high medicine prices therefore threaten the feasibility and sustainability of nascent schemes for universal health coverage (UHC). We argue that a strategic system of value-based tiered pricing (VBTP), wherein each country would pay a price for each health product commensurate with the local value it provides, could improve access, enhance efficiency, and empower countries to negotiate with product manufacturers. This paper attempts to further understanding on the potential value of tiered pricing, barriers to its implementation, and potential strategies to overcome those.